» Articles » PMID: 6448611

Echocardiographic Differentiation of Hypertensive Heart Disease and Hypertrophic Cardiomyopathy

Overview
Journal Br Heart J
Date 1980 Oct 1
PMID 6448611
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

The clinical differentiation of hypertensive heart disease from hypertrophic cardiomyopathy usually presents no problem but it is less clear whether an echocardiographic distinction can always be made and, if so, what those echocardiographic criteria of difference are. It can be inferred from recent publications that when echocardiographic criteria for hypertrophic cardiomyopathy are met in hypertensive subjects, both diagnoses may be made. This may be unjustified, and in order to clarify this problem that M-mode echocardiographic features of 37 patients with severe systemic hypertension were compared with those of 70 patients with hypertrophoic cardiomyopathy and normal blood pressure. Systolic anterior movement of the mitral valve and/or mid-systolic closure of the aortic valve were found in 82 per cent of patients with obstructive and 35 per cent of patients with non-obstructive hypertrophic cardiomyopathy. These features were not seen in patients with hypertension. The conventional echocardiographic features of left ventricular hypertrophy and function did not permit distinction between hypertensive heart disease and hypertrophic cardiomyopathy. The echocardiographic diagnosis of hypertensive heart disease from hypertrophic cardiomyopathy is, therefore, difficult unless systolic anterior movement of the mitral valve and/or mid-systolic closure of the aortic valve can be shown.

Citing Articles

Indications for echocardiography and confirmation rates of cardiovascular diseases: experience of a specialist cardiac outpatient clinic in Kumasi, Ghana.

Wiafe Y, Acheamfour-Akowuah E, Owusu I Ann Afr Med. 2024; 22(4):440-445.

PMID: 38358143 PMC: 10775930. DOI: 10.4103/aam.aam_151_22.


Anderson-Fabry disease cardiomyopathy: an update on epidemiology, diagnostic approach, management and monitoring strategies.

Averbuch T, White J, Fine N Front Cardiovasc Med. 2023; 10:1152568.

PMID: 37332587 PMC: 10272370. DOI: 10.3389/fcvm.2023.1152568.


Multimodal deep learning enhances diagnostic precision in left ventricular hypertrophy.

Torres Soto J, Hughes J, Sanchez P, Perez M, Ouyang D, Ashley E Eur Heart J Digit Health. 2023; 3(3):380-389.

PMID: 36712167 PMC: 9707995. DOI: 10.1093/ehjdh/ztac033.


Cardiac Magnetic Resonance in Nonischemic Cardiomyopathies.

Yang E, Shah D Methodist Debakey Cardiovasc J. 2020; 16(2):97-105.

PMID: 32670469 PMC: 7350809. DOI: 10.14797/mdcj-16-2-97.


Evaluation and Management of Concomitant Hypertrophic Obstructive Cardiomyopathy and Valvular Aortic Stenosis.

Shenouda J, Silber D, Subramaniam M, Alkhatib B, Schwartz R, Goncalves J Curr Treat Options Cardiovasc Med. 2016; 18(3):17.

PMID: 26874705 DOI: 10.1007/s11936-016-0440-3.


References
1.
Moreyra E, Knibbe P, BREST A . Hypertension and muscular subaortic stenosis. Chest. 1970; 57(1):87-90. DOI: 10.1378/chest.57.1.87. View

2.
Alday L, Wagner H, VLAD P . Severe systemic hypertension and muscular subaortic stenosis. Am Heart J. 1972; 83(3):395-400. DOI: 10.1016/0002-8703(72)90443-7. View

3.
FEIGENBAUM H . Clinical applications of echocardiography. Prog Cardiovasc Dis. 1972; 14(6):531-58. DOI: 10.1016/0033-0620(72)90007-2. View

4.
HAMBY R, Roberts G, Meron J . Hypertension and hypertrophic subaortic stenosis. Am J Med. 1971; 51(4):474-81. DOI: 10.1016/0002-9343(71)90253-1. View

5.
Henry W, Clark C, Epstein S . Asymmetric septal hypertrophy. Echocardiographic identification of the pathognomonic anatomic abnormality of IHSS. Circulation. 1973; 47(2):225-33. DOI: 10.1161/01.cir.47.2.225. View